Objectives: There are limited data on the role of regulatory T cells (Treg) in the disease pathology of eosinophilic esophagitis (EoE). We tested the differences in Treg in subjects with EoE compared with those with gastroesophageal reflux disease (GERD) and healthy controls (HC).
Patients And Methods: Pediatric patients evaluated by endoscopy were recruited for our study. Participants were categorized into 3 groups: EoE, GERD, and HC. RNA purified from esophageal biopsies were used for real-time quantitative polymerase chain reaction assays and tested for forkhead box P3 (FoxP3) mRNA expression. Treg were identified as CD4+CD25hiCD127lo cells in peripheral blood and as CD3+/FoxP3+cells in esophageal tissue.
Results: Forty-eight subjects were analyzed by real-time quantitative polymerase chain reaction: EoE (n = 33), GERD (n = 7), and HC (n = 8). FoxP3 expression was higher by up to 1.5-fold in the EoE group compared with the GERD and HC groups (P < 0.05). Protein levels of FoxP3 in blood and tissue were then investigated in 21 subjects: EoE (n = 10), GERD (n = 6), and HC (n = 5). The percentage of Treg and their subsets in peripheral blood were not significant between groups (P > 0.05). The amount of Treg in esophageal tissue was significantly greater in the EoE group (mean 10.7 CD3+/FoxP3+cells/high power field [HPF]) compared with the other groups (GERD, mean 1.7 CD3+/FoxP3+cells/HPF and HC, mean 1.6 CD3+/FoxP3+cells/HPF) (P < 0.05).
Conclusions: We show that Treg are increased in esophageal tissue of EoE subjects compared with GERD and HC subjects. The present study illustrates another possible mechanism involved in EoE that implicates impairment of immune homeostasis.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1097/MPG.0b013e3181e0817b | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Prevalence and predictors of Barrett's esophagus and esophageal cancer in patients with eosinophilic esophagitis.
Dis Esophagus
January 2025
Department of Medicine, Division of Gastroenterology and Hepatology, Stanford University School of Medicine, Stanford, CAUSA.
Data on Barrett's esophagus (BE) and esophageal cancer (EC) outcomes in patients with eosinophilic esophagitis (EoE) are limited. We aimed to determine the risk of prevalent BE (<1 year after endoscopy), incident BE (≥1 year after endoscopy), and incident EC in patients with versus without EoE, and to identify predictors of BE/EC in EoE patients. We identified adult patients in the Merative MarketScan Database who underwent first-time upper endoscopy between 2008 and 2020.
View Article and Find Full Text PDF[EOSINOPHILIC ESOPHAGITIS: MUCH MORE IS UNKNOWN YET THAN DISCOVERED].
Harefuah
December 2024
Eosinophilic Gastrointestinal Disease Clinic, Gastroenterology and Hepatology Unit in collaboration with Immunology and Allergy Unit, Bnai Zion Medical Center, Haifa.
Eosinophilic esophagitis (EoE) is a chronic inflammatory disease of the esophagus, which is mediated by Th2 cells that could start at any age, from early childhood to adulthood. The pathogenesis of the disease is not fully understood, but apparently it consists of a combined interaction between hereditary and environmental factors. Over the years, EoE has become an increasingly diagnosed disease in the context of esophageal symptoms.
View Article and Find Full Text PDFReflux, eosinophilic esophagitis, and celiac disease - the blurred lines.
Curr Opin Otolaryngol Head Neck Surg
December 2024
Department of Medicine, Division of Gastroenterology and Hepatology, Stanford University, Stanford, California, USA.
Article Synopsis
- Gastroesophageal reflux disease (GERD) is a common cause of dysphagia, while eosinophilic esophagitis (EoE) and celiac disease are rarer but often overlooked, making diagnosis challenging due to symptom overlap.
- Recent research has improved understanding of how dysphagia manifests in these conditions, emphasizing the importance of tests like upper endoscopy and biopsies, while also introducing new diagnostic methods.
- Properly distinguishing between GERD, EoE, and celiac disease is essential for effective treatment; EoE should be suspected in GERD patients who don't respond to standard therapy, and celiac disease should be considered if dysphagia occurs with
Esophagitis, treatment outcomes, and long-term follow-up in children with esophageal atresia.
J Pediatr Gastroenterol Nutr
December 2024
Division of Pediatric Gastroenterology, Hepatology and Nutrition, Department of Pediatrics, Medical College of Wisconsin, Milwaukee, Wisconsin, USA.
Objectives: Survival rates in children born with esophageal atresia (EA) with or without tracheoesophageal fistula (TEF) have improved; however, morbidity associated with the disease remains high. This study aimed to assess the prevalence of gastroesophageal reflux disease (GERD), eosinophilic esophagitis (EoE), fungal esophagitis, esophageal strictures, and long-term outcomes in children with EA/TEF.
Methods: We conducted a retrospective chart review on patients with EA/TEF who were seen at Children's Wisconsin from January 2003 to January 2023.
EoE Recurrence on PPI Maintenance Therapy: You Do Not Know if You Do Not Look!
Dig Dis Sci
November 2024
Department of Gastroenterology and Hepatology, Mayo Clinic Rochester, Rochester, USA.
Background And Aims: Data regarding histologic recurrence of EoE on PPI maintenance therapy are lacking.
Methods: Retrospective review of 101 patients with histologic PPI-responsive EoE.
Results: 52/101 (51%) patients underwent follow-up EGD with biopsies.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!